Rhythm Pharmaceuticals (RYTM) Return on Capital Employed (2017 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Return on Capital Employed of 55.12% for Q1 2026, up 705.0% year-over-year from 6.85% in Q1 2025, and down 11.27% quarter-over-quarter from 49.54% in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Return on Capital Employed (2017 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 10 years of Return on Capital Employed data on file, last reported at 55.12% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 55.12%, up 705.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 55.12% (up 705.0% YoY), and the FY2025 annual result was 58.14%, up 4936.0% from the prior year.
- Return on Capital Employed retreated to 55.12% in Q1 2026 per RYTM's latest filing, from 49.54% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 49.54% in Q4 2025 and troughed at 112.49% in Q1 2024.
- A 5-year average of 71.87% and a median of 64.08% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed plunged 5621 bps in 2024, then surged 5164 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 51.74% in 2022, then retreated by 24 bps to 63.95% in 2023, then sank by 58 bps to 101.18% in 2024, then surged by 51 bps to 49.54% in 2025, then decreased by 11 bps to 55.12% in 2026.
- Business Quant data shows RYTM's Return on Capital Employed at 55.12% in Q1 2026, 49.54% in Q4 2025, and 55.5% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | -55.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.12% |
| Dec 31, 2025 | -49.54% |
| Sep 30, 2025 | -55.50% |
| Jun 30, 2025 | -70.90% |
| Mar 31, 2025 | -62.17% |
| Dec 31, 2024 | -101.18% |
| Sep 30, 2024 | -96.51% |
| Jun 30, 2024 | -100.02% |
| Mar 31, 2024 | -112.49% |
| Dec 31, 2023 | -63.95% |
| Sep 30, 2023 | -65.69% |
| Jun 30, 2023 | -64.08% |
| Mar 31, 2023 | -56.28% |
| Dec 31, 2022 | -51.74% |
| Sep 30, 2022 | -62.57% |
| Jun 30, 2022 | -81.55% |
| Mar 31, 2022 | -72.47% |
| Dec 31, 2021 | -56.83% |
| Sep 30, 2021 | -44.21% |
| Jun 30, 2021 | -37.18% |